Machine Learning-Based Prediction of Major Perioperative Allogeneic Blood Requirements in Cardiac Surgery
NCT04856618 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3782
Last updated 2022-11-29
Summary
Cardiac surgery is one of the clinical surgical specialties that carries a particularly high risk for patients to suffer from severe bleeding perioperatively and consequent anemia, which subsequently requires transfusion of allogeneic blood.
Although a surprisingly high number of patients in cardiac surgery do not require perioperative transfusions, it is primarily those patients who do require transfusion who are subsequently at risk for a worse outcome.
In recent years many studies have been published discussing measures that can assist physicians in avoiding the triad of anemia, bleeding, and transfusion in cardiac surgery. Within these publications, the implementation of Patient Blood Management (PBM) is advised. PBM is a set of measures aimed at improving patient outcome by reducing perioperative bleeding and thus preventing both anemia and bleeding.
The three pillars of this bundle are the preoperative preparation of anemic patients with iron, erythropoietin, folic acid and vitamin B12, the prevention of intraoperative blood loss and the reasonable indication for allogeneic transfusions.
Nevertheless, it must be mentioned that the implementation of at least part of these measures is laborious, and full implementation of the recommended bundle is therefore rarely achieved. As a consequence, the full potential of Patient Blood Management is not always realized. Unfortunately this means that transfusion of allogeneic blood cannot be prevented in many patients.
A small proportion of patients undergoing cardiac surgery requires a very large amount of allogeneic blood perioperatively. These patients are typically those with a particularly poor outcome. Massive transfusion of allogeneic blood in this situation is an indicator of complications and a cause of increased mortality.
Although cardiac surgeons and anesthesiologists believe they can assess which patients are at high risk for hemorrhage, recent publications indicate that there is an urgent need for adequate predictive methods. A variety of studies exist that attempt to predict perioperative transfusion requirements, but to date have been plagued by several limitations. Either the previous publications do not focus on the prediction of massive transfusion of allogeneic blood, i.e. administration of ten or more packed red blood cell units perioperatively, but on much lower transfusion volumes, have only low predictive strength to predict massive transfusion in daily clinical practice, or are hardly usable for true prediction because they use factors (features) that are not strictly present only in the preoperative phase.
If an accurate prediction model based on a few features could be created and those patients particularly at risk of massive transfusion of allogeneic blood could be identified, it would subsequently be possible to develop an adapted clinical pathway that would allow patient care to be improved and individualized interventions adapted to the situation to be implemented.
In the best case, an adapted care of patients would be possible, which is able to increase the acceptance for the use of even complex measures of patient blood management. This is especially true for measures such as preoperative preparation with iron and/or erythropoietin, the use of a cell saver, and a particularly careful surgical approach.
Even if it is difficult to apply all measures of patient blood management in all patients, it would be possible with an approach as described to identify those patients who would benefit most from individualized approaches.
Conditions
- Transfusion-dependent Anemia
Interventions
- BIOLOGICAL
-
Massive Transfusion of Allogeneic Blood
Massive Transfusion of Allogeneic Blood, \> pRBCs
Sponsors & Collaborators
-
Kepler University Hospital
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-06-16
- Primary Completion
- 2021-06-30
- Completion
- 2022-07-20
Countries
- Austria
Study Locations
More Related Trials
-
Balancing Risk: Red Blood Cell Transfusion Strategies In Cardiac Surgery
NCT00651573 ·Status: COMPLETED ·Phase: NA
-
Advance Targeted Transfusion in Anemic Cardiac Surgical Patients for Kidney Protection: A Proof of Concept Pilot Study
NCT00861822 ·Status: COMPLETED ·Phase: PHASE1
-
Patient Blood Management in Cardiac Surgery
NCT04040023 ·Status: COMPLETED ·Phase: NA
-
Impact of Perioperative Allogeneic Red Blood Cell Transfusion on Postoperative Myocardial Injury After Liver Resection
NCT07125612 ·Status: COMPLETED
-
Blood Products in Cardiac Surgery
NCT02068755 ·Status: COMPLETED
-
Liberal Transfusion Strategy in Elderly Patients
NCT03369210 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Safety and Effectiveness of Two Blood Transfusion Strategies in Surgical Patients With Cardiovascular Disease
NCT00071032 ·Status: COMPLETED ·Phase: PHASE3
-
AI-driven Clinical Decision Support for Perioperative Blood Orders
NCT07223853 ·Status: RECRUITING ·Phase: NA
-
A Preliminary Study of a New Tranexamic Acid Dosing Schedule for Cardiac Surgery
NCT00588133 ·Status: COMPLETED ·Phase: PHASE3
-
Effectiveness of a Intraoperative Blood Recovery System in Cardiovascular Surgery in Brazil
NCT06601582 ·Status: RECRUITING ·Phase: NA
-
Acute Normovolemic Hemodilution in Complex Cardiac Surgery
NCT05049590 ·Status: COMPLETED ·Phase: PHASE3
-
Patient Blood Management in Cardiac Surgery in Turkiye
NCT06084871 ·Status: RECRUITING
-
AutoTransfusion Versus TRAnsfusion in Cancer Surgery
NCT05452538 ·Status: COMPLETED
-
Early Whole Blood in Patients Requiring Transfusion After Major Trauma
NCT01227005 ·Status: COMPLETED ·Phase: PHASE4
-
Allogenic Blood Transfusion During Elective Open Abdominal Aortic Surgery
NCT03891303 ·Status: COMPLETED
-
Development of a Predictive Algorithm for a Hemoglobin Value of Less Than 10 g/dl Postoperatively in Scheduled Hip or Knee Arthroplasty
NCT05605860 ·Status: COMPLETED
-
Primary and Secondary Hemostasis in Elective Coronary Artery Bypass Graft Surgery
NCT00825981 ·Status: COMPLETED
-
Epidemiology of Severe Peroperative Bleeding During Scheduled Surgery
NCT02311309 ·Status: COMPLETED
-
Bleeding Prediction in Patients Following Cardiac Surgery Using Whole Blood Aggregometry and Thromboelastometry
NCT01281397 ·Status: TERMINATED
-
Impact of Acute Normovolemic Hemodilution on Blood Viscosity
NCT03366753 ·Status: COMPLETED ·Phase: NA
-
Restrictive Versus Liberal Red Cell Transfusion Strategy in Orthopedic-Oncology Patients Undergoing Surgery - a Randomized Controlled Study
NCT01491308 ·Status: UNKNOWN ·Phase: NA
-
Comparison of Aprotinin and Tranexamic Acid in Routine Cardiac Surgery
NCT00396760 ·Status: UNKNOWN ·Phase: PHASE3
-
Goal-orientated Therapy of Perioperative Disturbance in Hemostasis in Cardiac Surgery
NCT00516126 ·Status: COMPLETED
-
Preoperative Anaemia prevaLence In surgiCal patiEnts
NCT03978260 ·Status: COMPLETED
-
The Effect of Tranexamic Acid on Postoperative Blood Loss and Coagulation in Patients With Preoperative Anemia Undergoing Off-Pump Coronary Artery Bypass Graft; Double Blind Randomized Control Study
NCT01067638 ·Status: COMPLETED ·Phase: PHASE4